Skip to main content
OpenTrials
Completed

NCT Number: NCT06290674

Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile

Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Helwan General Hospital

Cairo, Helwan, Cairo Governate, 02, Egypt

About this study

Postmenopausal women are usually troubled by increasing weight and waist circumference caused by obesity and androcidal fat redistribution. Abdominal adiposity, defined as a waist circumference ≥88cm in women, measured in the upright position, plus significant elevated lipid profile values. In postmenopausal women, a higher level of physical activity was associated with a more optimal body composition, including lower adiposity and higher lean mass. Management of abdominal obesity involves different techniques i.e., dietary management, exercise therapy, even lifestyle management, and pharmacological management, and surgical interventions. Extracorporeal shockwave provides cavitation phenomena that may facilitate better management of abdominal obesity. Thus, current study will be conducted to investigate effect of extracorporeal shockwave on abdominal adiposity and lipid profile in obese post-menopausal women.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Their age range 45-60 years old.
  • Their body mass index range 30-35 kg/m square.
  • Only, obese postmenopausal women with at least one year after stoppage of menses.

Exclusion criteria

  • Receiving pharmacological treatment.
  • Receiving any form of electrotherapy.
  • Whom with metabolic, hematological or renal dysfunction.
  • Whom have dermatological or cardiovascular or respiratory, digestive or rheumatic disorders.

Treatment and study plan

Extracorporeal Shockwave Therapy

Other

2000 shots, 120mJ pulse energy setting, 3 bar pressure, and 15 Hz for 15 minute per session.

Balanced low-calorie diet

Other

1500 k/cal for 6 weeks

Primary outcomes

  1. Waist/ hip ratio

    Time frame: Pretreatment and Posttreatment of six weeks study protocol.

    anthropometric outcome measure for abdominal adiposity

  2. Skin fold caliper

    Time frame: Pretreatment and Posttreatment of six weeks study protocol.

    subcutaneous fat outcome measure

Secondary outcomes

  1. Lipid profile

    Time frame: Pretreatment and Posttreatment of six weeks study protocol.

    Low-density lipoprotein, High-density lipoprotein, and triglyceride laboratory outcome measures.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Effect of Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile in Obese Postmenopausal Women

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Mar 4, 2024
Registry last updated
Jul 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.